Hepatitis C: Treatment of difficult to treat patients-Reference-Cited by-同舟云学术

Hepatitis C: Treatment of difficult to treat patients

Published:2015 Issue:15 Volume:7 Page:1953
ISSN:1948-5182
Container-title:World Journal of Hepatology
language:en
Short-container-title:WJH

Author:

Hilgenfeldt Eric G

Publisher

Baishideng Publishing Group Inc.

Subject

Hepatology

Reference59 articles.

1. Chronic Hepatitis C Virus Infection in the United States, National Health and Nutrition Examination Survey 2003 to 2010

2. WHO. Hepatitis C, Fact sheet N°164. [Updated 2014 April] Available from: http://www.who.int/mediacentre/factsheets/fs164/en/.

3. American Association for the Study of Liver Diseases and the Infectious Diseases Society of America. Recommendations for Testing, Managing, and Treating Hepatitis C. Available from: http://www.hcvguidelines.org.

4. Daclatasvir plus Sofosbuvir for Previously Treated or Untreated Chronic HCV Infection

5. Telaprevir for Retreatment of HCV Infection

Cited by 22 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Treatment with Sofosbuvir/Velpatasvir of the most difficult to cure HCV-infected population;Polish Archives of Internal Medicine;2024-01-02

2. Hepatitis C Risk Prediction Based on Adaboost;Highlights in Science, Engineering and Technology;2023-07-04

3. The risks of hepatocellular carcinoma and variceal bleeding after HCV eradication with direct-acting antiviral therapy: a propensity score analysis;Revista Medico-Chirurgicala;2021-03-30

4. Extended panel of biomarkers for long term monitoring of effectiveness of 3 direct antiviral regimen in HCV genotype 1b infection: results from a Romanian infectious disease hospital;Revista Romana de Medicina de Laborator;2021-01-01

5. Eight Weeks of Treatment With Glecaprevir/Pibrentasvir Is Safe and Efficacious in an Integrated Analysis of Treatment-Naïve Patients With Hepatitis C Virus Infection;Clinical Gastroenterology and Hepatology;2020-10